The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders.
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders.
What's Your Reaction?
Hemanth Kumar Gorle
Mr. Hemanth Kumar Gorle, founder of Indian Web Services, specializes in web development, hosting, and online marketing. He is dedicated to creating effective digital solutions and fostering successful business relationships through his expertise and strategic approach.
